Search Results Search Sort by RelevanceMost Recent History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408. Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373. Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408. Pagination First page « First Previous page ‹ Previous Page 1 Current page 2
History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408.
Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373.
Case and Commentary Aug 2004 Helping Surrogate Decision Makers in the Face of Uncertainty Robert W. Taylor, MD Physicians need to help surrogate decision makers to make treatment and end-of-life decisions for those with severe neurological damage by proving a realistic prognosis and maintain strong lines of communication. Virtual Mentor. 2004;6(8):342-344. doi: 10.1001/virtualmentor.2004.6.8.ccas2-0408.